InnovAge (INNV) Stock: Why It Rose
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $8.88, +0.34% vs the prior close of $8.85.
- Volume 288.80K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GeneDx (WGS)LifeStance Health (LFST)Privia Health (PRVA)Omada Health (OMDA)U S Physical Therapy (USPH)Pennant (PNTG)
INNV rises 0.3% to $8.88. Closed at $8.88, +0.34% vs the prior close of $8.85. Day range $8.81–$8.96, opened at $8.88.
INNV daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — INNV rises 0.3% to $8.88
- Closed at $8.88, +0.34% vs the prior close of $8.85. Day range $8.81–$8.96, opened at $8.88.
- Volume was 271.02K shares, 0.5x its 50-day average of 519.90K — lighter than usual.
- Price is -12.1% vs its 50-day average ($10.10) and -0.1% vs its 200-day average ($8.89).
- 52-week range $3.93–$12.64; today's close sits at 57% of that range, 29.7% below the 52-week high.
Oct 16, 2026 — INNV dips 1.4% to $8.85
- Closed at $8.85, -1.45% vs the prior close of $8.98. Day range $8.79–$9.08, opened at $9.02.
- Volume was 381.99K shares, 0.7x its 50-day average of 515.18K.
- Price is -12.8% vs its 50-day average ($10.14) and -0.3% vs its 200-day average ($8.87).
- 52-week range $3.93–$12.64; today's close sits at 56% of that range, 30.0% below the 52-week high.
Oct 15, 2026 — INNV dips 1.1% to $8.98
- Closed at $8.98, -1.10% vs the prior close of $9.08. Day range $8.91–$9.23, opened at $9.18.
- Volume was 307.90K shares, 0.6x its 50-day average of 512.43K.
- Price is -11.8% vs its 50-day average ($10.19) and +1.4% vs its 200-day average ($8.86).
- 52-week range $3.93–$12.64; today's close sits at 58% of that range, 29.0% below the 52-week high.
Oct 14, 2026 — INNV rises 0.7% to $9.08
- Closed at $9.08, +0.67% vs the prior close of $9.02. Day range $8.94–$9.12, opened at $8.95.
- Volume was 357.50K shares, 0.7x its 50-day average of 510.99K.
- Price is -11.2% vs its 50-day average ($10.23) and +2.7% vs its 200-day average ($8.84).
- 52-week range $3.93–$12.64; today's close sits at 59% of that range, 28.2% below the 52-week high.
Oct 13, 2026 — INNV dips 1.4% to $9.02
- Closed at $9.02, -1.42% vs the prior close of $9.15. Day range $8.94–$9.23, opened at $9.17.
- Volume was 457.30K shares, 0.9x its 50-day average of 508.78K.
- Price is -12.1% vs its 50-day average ($10.26) and +2.3% vs its 200-day average ($8.82).
- 52-week range $3.93–$12.64; today's close sits at 58% of that range, 28.6% below the 52-week high.
Oct 12, 2026 — INNV rises 0.5% to $9.15
- Closed at $9.15, +0.55% vs the prior close of $9.10. Day range $9.04–$9.22, opened at $9.04.
- Volume was 315.40K shares, 0.6x its 50-day average of 509.50K.
- Price is -11.2% vs its 50-day average ($10.31) and +3.9% vs its 200-day average ($8.80).
- 52-week range $3.93–$12.64; today's close sits at 60% of that range, 27.6% below the 52-week high.
Oct 9, 2026 — INNV ends flat (-0.1%) to $9.10
- Closed at $9.10, -0.11% vs the prior close of $9.11. Day range $9.08–$9.27, opened at $9.11.
- Volume was 343.10K shares, 0.7x its 50-day average of 505.65K.
- Price is -12.1% vs its 50-day average ($10.35) and +3.6% vs its 200-day average ($8.79).
- 52-week range $3.93–$12.64; today's close sits at 59% of that range, 28.0% below the 52-week high.
Oct 8, 2026 — INNV ends flat (-0.2%) to $9.11 on 2.4x normal volume
- Closed at $9.11, -0.22% vs the prior close of $9.13. Day range $8.91–$9.18, opened at $9.18.
- Volume was 1.18M shares, 2.4x its 50-day average of 485.35K — unusually heavy trading.
- Price is -12.4% vs its 50-day average ($10.40) and +3.9% vs its 200-day average ($8.77).
- 52-week range $3.93–$12.64; today's close sits at 59% of that range, 27.9% below the 52-week high.
Oct 7, 2026 — INNV rises 1.4% to $9.13
- Closed at $9.13, +1.44% vs the prior close of $9.00. Day range $8.91–$9.19, opened at $8.91.
- Volume was 342.20K shares, 0.7x its 50-day average of 484.42K.
- Price is -12.6% vs its 50-day average ($10.45) and +4.3% vs its 200-day average ($8.75).
- 52-week range $3.93–$12.64; today's close sits at 60% of that range, 27.8% below the 52-week high.
Oct 6, 2026 — INNV ends flat (+0.0%) to $9.00
- Closed at $9.00, +0.00% vs the prior close of $9.00. Day range $8.89–$9.16, opened at $9.01.
- Volume was 362.40K shares, 0.8x its 50-day average of 481.90K.
- Price is -14.3% vs its 50-day average ($10.50) and +3.0% vs its 200-day average ($8.74).
- 52-week range $3.93–$12.64; today's close sits at 58% of that range, 28.8% below the 52-week high.
Oct 5, 2026 — INNV rises 0.4% to $9.00 on 1.9x normal volume
- Closed at $9.00, +0.45% vs the prior close of $8.96. Day range $8.84–$9.07, opened at $9.01.
- Volume was 878.30K shares, 1.9x its 50-day average of 467.78K — unusually heavy trading.
- Price is -14.7% vs its 50-day average ($10.55) and +3.2% vs its 200-day average ($8.72).
- 52-week range $3.93–$12.64; today's close sits at 58% of that range, 28.8% below the 52-week high.
Oct 2, 2026 — INNV rises 1.8% to $8.96 on 2.6x normal volume
- Closed at $8.96, +1.82% vs the prior close of $8.80. Day range $8.74–$9.08, opened at $8.90.
- Volume was 1.18M shares, 2.6x its 50-day average of 448.71K — unusually heavy trading.
- Price is -15.5% vs its 50-day average ($10.60) and +2.9% vs its 200-day average ($8.71).
- 52-week range $3.93–$12.64; today's close sits at 58% of that range, 29.1% below the 52-week high.
INNV bull case vs bear case (from the data)
- Annual revenue grew 15.9% in the latest fiscal year (SEC XBRL).
- Price is -12.1% vs its 50-day average — short-term trend is down.
- Price is -0.1% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $2.54M.
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
INNV latest news & SEC filings
Every SEC filing by or about INNV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Damato Nicole sold 23,814 shares at $8.70 (≈$207.18K) on Sep 25, 2026; now holds 304,897
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Tco Group Holdings, L.P. sold 10,000,000 shares at $9.25 (≈$92.50M) on Sep 24, 2026; now holds 102,576,555
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ignite Aggregator Lp & Apax X (Guernsey) Usd Aiv Lp & Ignite Gp Inc. & Apax X Eur L.P. & Apax X Usd L.P. & Apax X Gp Co. Ltd sold 10,000,000 shares at $9.25 (≈$92.50M) on Sep 24, 2026; now holds 102,576,555
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Welsh, Carson, Anderson & Stowe Xii, L.P. & Wcas Co-Invest Associates Llc & Welsh, Carson, Anderson & Stowe Xii Delaware, L.P. & Welsh, Carson, Anderson & Stowe Xii Delaware Ii, L.P. & Welsh, Carson, Anderson & Stowe Xii Cayman, L.P. & Wcas Xii Co-Investors Llc & Wcas Management Corp & Wcas - Co-Invest Holdco, L.P. & Wcas Xii Associates Llc & Wcas Xii Associates Cayman, L.P. sold 10,000,000 shares on Sep 24, 2026; now holds 102,576,555
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 24, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 22, 2026 · Form 424B7 — Prospectus supplement for a resale by holders
Prospectus supplement for a resale by holders
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 9, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $989.71M (prior year $853.70M) (+15.9% vs Jun 30, 2025)
- Net income: -$2.54M (prior year -$30.31M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.02 (prior year -$0.22) (loss narrowed vs Jun 30, 2025)
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade INNV
- Last results release: Sep 8, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 3, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Dec 8, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.67% (largest 15.5%).
- Liquidity: about 944.04K shares (≈$8.38M) trade per day on average.
- 52-week position: $8.88 vs a range of $3.93–$12.64 (57% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Nicole Damato sold 23,814 shares on Sep 25, 2026.
- Latest filings: 8-K Sep 24, 2026; 10-K Sep 9, 2026; 8-K Sep 8, 2026.
- Share count: 136.45M shares outstanding (Sep 1, 2026), +0.6% vs a year earlier.
- Listing: Nasdaq · industry: Services-Health Services.
INNV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 8.88 | 8.96 | 8.81 | 8.88 | 288.80K |
| Oct 16, 2026 | 9.02 | 9.08 | 8.79 | 8.85 | 382.00K |
| Oct 15, 2026 | 9.18 | 9.23 | 8.91 | 8.98 | 307.90K |
| Oct 14, 2026 | 8.95 | 9.12 | 8.94 | 9.08 | 357.50K |
| Oct 13, 2026 | 9.17 | 9.23 | 8.94 | 9.02 | 457.30K |
| Oct 12, 2026 | 9.04 | 9.22 | 9.04 | 9.15 | 315.40K |
| Oct 9, 2026 | 9.11 | 9.27 | 9.08 | 9.10 | 343.10K |
| Oct 8, 2026 | 9.18 | 9.18 | 8.91 | 9.11 | 1.18M |
| Oct 7, 2026 | 8.91 | 9.19 | 8.91 | 9.13 | 342.20K |
| Oct 6, 2026 | 9.01 | 9.16 | 8.89 | 9.00 | 362.40K |
| Oct 5, 2026 | 9.01 | 9.07 | 8.84 | 9.00 | 878.30K |
| Oct 2, 2026 | 8.90 | 9.08 | 8.74 | 8.96 | 1.18M |
| Oct 1, 2026 | 8.78 | 9.00 | 8.60 | 8.80 | 462.00K |
| Sep 30, 2026 | 8.95 | 8.95 | 8.72 | 8.80 | 807.60K |
| Sep 29, 2026 | 8.80 | 9.00 | 8.69 | 8.98 | 729.10K |
| Sep 28, 2026 | 8.99 | 9.26 | 8.82 | 8.89 | 725.50K |
| Sep 25, 2026 | 8.79 | 9.12 | 8.40 | 9.00 | 1.54M |
| Sep 24, 2026 | 9.03 | 9.03 | 8.55 | 8.84 | 1.30M |
| Sep 23, 2026 | 9.73 | 9.75 | 8.92 | 9.00 | 6.58M |
| Sep 22, 2026 | 10.63 | 10.81 | 10.45 | 10.65 | 339.80K |
About InnovAge
InnovAge (INNV) is listed on the Nasdaq and classified by the SEC under “Services-Health Services”. Its business address is in DENVER, CO. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 1834376.
INNV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John Ellis Bush | Director | Jul 2, 2026 |
| James G Carlson | Director | Jul 2, 2026 |
| Patricia Fontneau | Director | Jul 2, 2026 |
| Edward Moore Jr. Kennedy | Director | Jul 2, 2026 |
| Pavithra Mahesh | Director | Jan 30, 2026 |
| Teresa Sparks | Director | Jul 2, 2026 |
| Marilyn B Tavenner | Director | Jul 2, 2026 |
| Sean Traynor | Director | Jan 30, 2026 |
| Richard C Zoretic | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Benjamin C Adams | CHIEF FINANCIAL OFFICER | Jul 23, 2026 |
| Patrick T Blair | CHIEF EXECUTIVE OFFICER | Jul 27, 2026 |
| Jennifer Browne | President and COO | Jun 8, 2026 |
| Nicole Damato | CHIEF LEGAL OFFICER | Sep 29, 2026 |
| Meredith Delk | Chief Administrative Officer | Jul 23, 2026 |
| Michael Anthony Scarbrough | President and COO | Nov 17, 2025 |
| Paul Taheri | Chief Medical Officer | Aug 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 25, 2026 | Nicole Damato | Sale | 23,814 | $8.70 |
| Sep 25, 2026 | Nicole Damato | Sale | 23,814 | $8.70 |
| Sep 25, 2026 | Nicole Damato | Sale | 23,814 | $8.70 |
| Sep 25, 2026 | Nicole Damato | Sale | 23,814 | $8.70 |
| Sep 24, 2026 | Co-Invest Associates Llc Wcas | Sale | 10,000,000 | — |
| Sep 24, 2026 | Co-Invest Associates Llc Wcas | Sale | 10,000,000 | — |
| Sep 24, 2026 | Carson, Anderson & Stowe Xii Delaware Ii, L.P. Welsh, | Sale | 10,000,000 | — |
| Sep 24, 2026 | Carson, Anderson & Stowe Xii Delaware Ii, L.P. Welsh, | Sale | 10,000,000 | — |
| Sep 24, 2026 | Carson, Anderson & Stowe Xii Cayman, L.P. Welsh, | Sale | 10,000,000 | — |
| Sep 24, 2026 | Carson, Anderson & Stowe Xii Cayman, L.P. Welsh, | Sale | 10,000,000 | — |
| Sep 24, 2026 | Carson, Anderson & Stowe Xii Delaware, L.P. Welsh, | Sale | 10,000,000 | — |
| Sep 24, 2026 | Carson, Anderson & Stowe Xii Delaware, L.P. Welsh, | Sale | 10,000,000 | — |
| Sep 24, 2026 | - Co-Invest Holdco, L.P. Wcas | Sale | 10,000,000 | — |
| Sep 24, 2026 | - Co-Invest Holdco, L.P. Wcas | Sale | 10,000,000 | — |
| Sep 24, 2026 | Xii Associates Llc Wcas | Sale | 10,000,000 | — |
INNV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $989.71M | $-2.54M | -0.02 | $64.71M |
| Jun 30, 2025 | $853.70M | $-30.31M | -0.22 | $32.87M |
| Jun 30, 2024 | $763.86M | $-21.34M | -0.16 | $-36.90M |
| Jun 30, 2023 | $688.09M | $-40.67M | -0.30 | $20.24M |
| Jun 30, 2022 | $698.64M | $-6.52M | -0.05 | $27.30M |
Latest balance sheet: total assets $557.39M, total liabilities $288.62M, cash $97.89M (as of Jun 30, 2026).
INNV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Sep 8, 2026 | 8-K Item 2.02 (results) | $10.52 |
| May 5, 2026 | 8-K Item 2.02 (results) | $7.96 |
| Feb 3, 2026 | 8-K Item 2.02 (results) | $5.66 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $4.84 |
| Sep 9, 2025 | 8-K Item 2.02 (results) | $4.27 |
| May 6, 2025 | 8-K Item 2.02 (results) | $2.85 |
| Feb 4, 2025 | 8-K Item 2.02 (results) | $3.69 |
| Nov 5, 2024 | 8-K Item 2.02 (results) | $6.07 |
| Sep 10, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 6, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Health Services
GeneDx (WGS)LifeStance Health (LFST)Privia Health (PRVA)Omada Health (OMDA)U S Physical Therapy (USPH)Pennant (PNTG)Strata Critical Medical (SRTA)EUDA Health (EUDA)DocGo (DCGO)Agape ATP (ATPC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on INNV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.